5/11/2022 6:32:04 AM
Johnson & Johnson Names Thibaut Mongon As CEO And Paul Ruh As CFO Of The Future, Listed New Consumer Health Company
4/25/2022 7:32:40 AM
Johnson & Johnson Unveils Satellite Center For Global Health Discovery At Holistic Drug Discovery And Development Centre
4/19/2022 6:26:48 AM
Johnson & Johnson Q1 EPS $1.93; Adj EPS $2.67
4/19/2022 6:22:23 AM
Johnson & Johnson (JNJ) Declares Quarterly Dividend of $ 1.13, Record Date 5/24/2022
4/19/2022 6:21:36 AM
Johnson & Johnson Declares 6.6% Increase In Quarterly Dividend To $1.13/Shr; Record May 24/payable June 7
3/1/2022 6:27:05 AM
Pathalys Pharma Acquires License To EA Pharma's Upacicalcet Worldwide Outside Of Japan And Asia